ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©ÈÙ»ñ¡¶2023ÖйúÒ©Æ·Ñз¢ÊµÁ¦ÅÅÐаñ¡·ÏµÁаñµ¥ÈýÏî´ó½±
2023Äê6ÔÂ16-17ÈÕ£¬£¬£¬£¬£¬ÓÉÒ©ÖÇÍø¡¢ÖйúÒ©ÒµÔÓÖ¾ÉçÖ÷ÀíµÄ¡°2023´ó¿µ½¡¹¤Òµ¸ßÖÊÁ¿´ó»áôߵڰ˽ìÖйúÒ½Ò©Ñз¢¡¤Á¢Òì·å»á£¨PDI£©¡±ÔÚÖØÇì¾ÙÐС£¡£¡£¡£¡£Îª¾ò¿Í·¢¶¯Ò½Ò©Ñз¢µÄË¢ÐÂʵÁ¦£¬£¬£¬£¬£¬ËÌÑï¿ÆÑ§Ì½Ë÷¾«Éñ£¬£¬£¬£¬£¬Íƶ¯Ò½Ò©¹¤ÒµÁ¢ÒìÉú³¤£¬£¬£¬£¬£¬´ó»áÆÀÑ¡³ö¡¶2023ÖйúÒ©Æ·Ñз¢ÊµÁ¦ÅÅÐаñ¡·ÏµÁаñµ¥¡£¡£¡£¡£¡£ÉϺ£ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©£¨¼¯ÍÅ£©¹É·ÝÓÐÏÞ¹«Ë¾£¨¡°ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©¡±?£¬£¬£¬£¬£¬¹ÉƱ´úÂ룺600196.SH £¬£¬£¬£¬£¬02196.HK ?£©Èٵǡ¶2023ÖйúÒ©Æ·Ñз¢×ÛºÏʵÁ¦ÅÅÐаñ¡·£¨×ܰñ£©µÚ¶þÃû¡¢¡¶2023ÖйúÉúÎïÒ©Ñз¢ÊµÁ¦ÅÅÐаñ¡·£¨ÉúÎïÒ©°ñ£©°ñÊס£¡£¡£¡£¡£

ÍõÐËÀû²©Ê¿£ºÐ¯È«ÇòÒ©ÑÐÂÄÀú£¬£¬£¬£¬£¬ÖúÖйúÐÂÒ©Éú³¤
ÍõÐËÀû²©Ê¿
ÍõÐËÀû²©Ê¿ÓÚ2023Äê1Ô¼ÓÈëÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©¼¯ÍÅ£¬£¬£¬£¬£¬ÏÖÈÎÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©Ö´ÐÐ×ܲá¢ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©Á¢ÒìÒ©ÊÂÒµ²¿ÁªÏ¯Ê×ϯִÐй٣¨ÁªÏ¯CEO£©¡¢È«ÇòÑз¢ÖÐÐÄÊ×ϯִÐй٣¨CEO£©¡£¡£¡£¡£¡£¼ÓÈëÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©¼¯ÍÅǰ£¬£¬£¬£¬£¬Íõ²©Ê¿ÏȺóÔøÔÚÃÀ¹úÏÈÁéÝáÑÅ, Ĭɳ¶«¡¢Åµ»ªÒ©Î﹫˾µ£µ±²î±ðµÄÏòµ¼ÖÎÀíÖ°Îñ£¬£¬£¬£¬£¬ÔÚÈ«ÇòÒ©Æ·Ñз¢·½Ãæ¾ßÓи»ºñÂÄÀú£¬£¬£¬£¬£¬Ïòµ¼ÁËÖî¶à´óÐÍÈ«ÇòÁÙ´²ÊÔÑé²¢ÀÖ³ÉÌá½»Á˶àÏîIND/NDAÉêÇë¡£¡£¡£¡£¡£
Éî¸ûÐÐÒµÊýÊ®ÔØ£¬£¬£¬£¬£¬ÍõÐËÀû²©Ê¿Ê¼ÖÕÐÄ»³ÔÚÒ½Ò©¿µ½¡ÁìÓòÒ»Ö±ÅÊÔµá¯ÁëµÄÈȳÀ¡£¡£¡£¡£¡£ÏÖÔÚ£¬£¬£¬£¬£¬ËûÒÑÊÇÃÀ¹ú±´ÀÕҽѧԺÖÕÉí½ÌÊÚ£¬£¬£¬£¬£¬Ôø»ñµÃÃÀ¹úÐÄѪ¹ÜлáµÄÓÅÒìѧÕß½±£¬£¬£¬£¬£¬É½¶«´óѧ³¤½Ñ§Õß¼°¹ú¼ÒÌØÆ¸½ÌÊÚ¡£¡£¡£¡£¡£Í¬Ê±£¬£¬£¬£¬£¬ËûÕվɰĴóÀûÑÇ×¢²áִҵҽʦ¡£¡£¡£¡£¡£
ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©£ºÑз¢Í¶ÈëÒ»Á¬¼Ó´ó ¶à¿îÁ¢Òì²úÆ·¼ÓËÙÂ䵨
Á¢ÒìÑз¢ÊÇÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©µÄ½¹µãÉú³¤Çý¶¯Á¦£¬£¬£¬£¬£¬×÷Ϊһ¼ÒÖ²¸ùÖйú¡¢Á¢ÒìÇý¶¯µÄÈ«Çò»¯Ò½Ò©¿µ½¡¹¤Òµ¼¯ÍÅ£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©ÒÔ»¼ÕßΪÖÐÐÄ£¬£¬£¬£¬£¬ÁÙ´²ÐèÇóΪµ¼Ïò£¬£¬£¬£¬£¬Í¨¹ý×ÔÖ÷Ñз¢¡¢ÏàÖú¿ª·¢¡¢ÔÊÐíÒý½ø¡¢Éî¶È·õ»¯µÄ¿ª·Åʽ¡¢È«Çò»¯Á¢Òìģʽ£¬£¬£¬£¬£¬Ò»Á¬¸»ºñÁ¢Òì²úÆ·¹ÜÏß¡£¡£¡£¡£¡£
2023ÄêÒÔÀ´£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©¶à¿îÁ¢Òì²úÆ·¼°ÐÂ˳Ӧ֢»ñÅúÉÏÊУ¬£¬£¬£¬£¬Á¢ÒìתÐÍЧ¹ûÏÔÖø¡£¡£¡£¡£¡£¿ËÈÕ£¬£¬£¬£¬£¬È«ÇòȨÍþÒ½Ò©ÖÇ¿âÐÅϢƽ̨ Informa Pharma IntelligenceÐû²¼¡¶2023ÄêÒ½Ò©Ñз¢Ç÷ÊÆÄê¶ÈÆÊÎö¡·°×ƤÊ飨Pharma R&D Annual Review 2023£©£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©ÔÙ¶ÈÈëÑ¡¡°È«ÇòÒ½Ò©ÆóÒµÑз¢¹ÜÏß¹æÄ£Top25¡±°ñµ¥£¬£¬£¬£¬£¬Î»ÁÐÈ«ÇòµÚ24λ¡£¡£¡£¡£¡£
ÔÚÁ¢ÒìÑз¢µÄ»ù´¡ÉÏ£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©Í¨¹ýǰհÐÔµÄÈ«Çò»¯½á¹¹ÒÑÆðÔ´Ðγɺ¸ÇÑз¢¡¢Éú²ú¼°ÉÌÒµ»¯µÄÔËӪϵͳ£¬£¬£¬£¬£¬²¢Æð¾¢Íƶ¯ÓÅÖʲúÆ·³öº££¬£¬£¬£¬£¬ÒÀÍжàÄêµÄ¹¤ÒµÂÄÀú»ýµí¡¢¸ßÇ¿¶ÈÁ¢ÒìÑз¢Í¶ÈëºÍÈ«ÇòÇþµÀÍøÂ罨É裬£¬£¬£¬£¬ÒѾ߱¸ÐÐÒµÁìÏȵÄÈ«ÇòË«ÏòÔÊÐíÄÜÁ¦£¬£¬£¬£¬£¬ÖúÁ¦ÊµÏÖ×ÔÑвúÆ·ºÍÏàÖúÁ¢Òì²úÆ·µÄ¼ÛÖµ×î´ó»¯¡£¡£¡£¡£¡£Í¬Ê±£¬£¬£¬£¬£¬¼ÌÐøÌáÉýFIC£¨First-in-class£¬£¬£¬£¬£¬¼´Í¬ÀàÊ×´´£©ÓëBIC£¨Best-in-class£¬£¬£¬£¬£¬¼´Í¬Àà×î¼Ñ£©ÐÂÒ©µÄÑо¿ÓëÁÙ´²¿ª·¢ÄÜÁ¦£¬£¬£¬£¬£¬Ò»Ö±¸»ºñÁ¢Òì²úÆ·¹ÜÏßÒÔ½øÒ»²½Ç¿»¯ÆóÒµ½¹µã¾ºÕùÁ¦½¨Éè¡£¡£¡£¡£¡£
ÍõÐËÀû²©Ê¿µÄ¼ÓÈ룬£¬£¬£¬£¬ÎªÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©µÄÁ¢ÒìÑз¢ÏµÍ³ÖÎÀíÓëÉú³¤·¿ªÁËȫеÄÊ±ÊÆ¡£¡£¡£¡£¡£ÍõÐËÀû²©Ê¿ÒÔΪÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©Á¢ÒìÑз¢ÓÐÆäÆæÒìµÄÓÅÊÆ£º£¨ÑÓÕ¹ÔĶÁ£º×¨·ÃÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©ÍõÐËÀû£º³ÉΪһ¼ÒÈ«Çò»¯Ò©Æó£¬£¬£¬£¬£¬Òª×ö¶ÔÕ⼸¼þÊ£©
ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©µÄÁ¢ÒìÑз¢ÏµÍ³¾ß±¸·Ç³£¿£¿£¿£¿£¿ª·ÅµÄÑз¢Æ½Ì¨£¬£¬£¬£¬£¬Í¨¹ý²î±ðµÄÇþµÀ£¬£¬£¬£¬£¬°üÀ¨×ÔÖ÷Ñз¢¡¢ÏàÖú¿ª·¢¡¢ÔÊÐíÒý½øÓëÉî¶È·õ»¯¡£¡£¡£¡£¡£µ±°Ñƽ̨Öи÷ÇþµÀÂòͨʱ£¬£¬£¬£¬£¬»á·¢Ã÷ÕâÖÖ¿ª·Åʽƽ̨£¬£¬£¬£¬£¬¿ÉÒÔÓÃÏà¶Ô½ÏÉÙµÄ×ÊÔ´£¬£¬£¬£¬£¬Ç˶¯¸ü¶àµÄÁ¢ÒìÑз¢ÄÜÁ¦¡£¡£¡£¡£¡£µ±×ÔÑйÜÏßȱ·¦ÒÔʵÏÖÒ»¸öÆóÒµµÄÕ½ÂÔÄ¿µÄʱ£¬£¬£¬£¬£¬Õâʱ¼ä¿ÉÒÔͨ¹ýBDµÄ·½·¨À´Ôö²¹ÊµÏÖ¡£¡£¡£¡£¡£ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©Á¢Òì×îǿʢµÄÄÜÁ¦Ö®Ò»ÊÇÆäÔÚÈ«ÇòͶ×ʵÄÃôÈñ¶È£¬£¬£¬£¬£¬°üÀ¨Ö®Ç°Í¶×ÊйÚmRNAÒßÃ硢йڿڷþÒ©µÈ¡£¡£¡£¡£¡£Í¨¹ýÕâÑùµÄϵͳ£¬£¬£¬£¬£¬Ï£ÍûÎÒÃÇ¿ÉÒÔÓÐÒ»Ìì×öµ½ÏñÀÏÅÆMNCÒ»Ñù£¬£¬£¬£¬£¬Á¢ÒìÒ©³ÉΪÔÚÑвúÆ·¹ÜÏßµÄÖ÷Á÷£¬£¬£¬£¬£¬°Ñ¸ü¶àµÄÖйúÁ¢Òì´øµ½È«Çò£¬£¬£¬£¬£¬Ò²°ÑÌìÏÂÁ¢Òì´øµ½Öйú£¬£¬£¬£¬£¬²¢ÈÃÒ½Ò©Á¢ÒìµÄǰ½ø»Ý¼°ÌìÏÂÉÏËùÓв¡»¼¡£¡£¡£¡£¡£
ÃæÏòδÀ´£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©½«Ò»Á¬ÔÚ¡°4IN¡±£¨Á¢Òì Innovation¡¢¹ú¼Ê»¯ Internationalization¡¢ÖÇÄÜ»¯ Intelligentization¡¢ÕûºÏ Integration£©µÄÕ½ÂÔÖ¸µ¼Ï£¬£¬£¬£¬£¬³Ð¼Ì¡°Á¢ÒìתÐÍ¡¢ÕûºÏÔËÓª¡¢ÎȽ¡ÔöÌí¡±µÄÉú³¤Ä£Ê½ÒÔ¼°Îª¹É¶«´´Á¢¼ÛÖµµÄÐÅÐÄ£¬£¬£¬£¬£¬Ò»Ö±ÔöÇ¿×ÔÖ÷Ñз¢ÓëÍⲿÏàÖú£¬£¬£¬£¬£¬¸»ºñ²úÆ·¹ÜÏߣ¬£¬£¬£¬£¬Ç¿»¯È«Çò»¯½á¹¹£¬£¬£¬£¬£¬ÌáÉýÔËӪЧÂÊ£¬£¬£¬£¬£¬Í¬Ê±£¬£¬£¬£¬£¬Æð¾¢ÍƽøÒ½ÁÆ¿µ½¡¹¤ÒµÏßÉÏÏßϽṹ£¬£¬£¬£¬£¬ÖÂÁ¦ÓÚ³ÉΪȫÇòÒ½ÁÆ¿µ½¡Êг¡µÄÒ»Á÷ÆóÒµ¡£¡£¡£¡£¡£
¹ØÓÚÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©
ÉϺ£ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©£¨¼¯ÍÅ£©¹É·ÝÓÐÏÞ¹«Ë¾£¨¡°ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©¡±£¬£¬£¬£¬£¬¹ÉƱ´úÂ룺600196.SH£¬£¬£¬£¬£¬02196.HK£©½¨ÉèÓÚ1994 Ä꣬£¬£¬£¬£¬ÊÇÒ»¼ÒÖ²¸ùÖйú¡¢Á¢ÒìÇý¶¯µÄÈ«Çò»¯Ò½Ò©¿µ½¡¹¤Òµ¼¯ÍÅ£¬£¬£¬£¬£¬Ö±½ÓÔËÓªµÄÓªÒµ°üÀ¨ÖÆÒ©¡¢Ò½ÁÆÆ÷еÓëҽѧÕï¶Ï¡¢Ò½ÁÆ¿µ½¡Ð§ÀÍ£¬£¬£¬£¬£¬²¢Í¨¹ý²Î¹É¹úÒ©¿Ø¹ÉÁýÕÖµ½Ò½Ò©ÉÌÒµÁìÓò¡£¡£¡£¡£¡£
ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©ÒÔ»¼ÕßΪÖÐÐÄ¡¢ÁÙ´²ÐèÇóΪµ¼Ïò£¬£¬£¬£¬£¬Í¨¹ý×ÔÖ÷Ñз¢¡¢ÏàÖú¿ª·¢¡¢ÔÊÐíÒý½ø¡¢Éî¶È·õ»¯µÄ·½·¨£¬£¬£¬£¬£¬Ò»Á¬¸»ºñÁ¢Òì²úÆ·¹ÜÏߣ¬£¬£¬£¬£¬ÌáÉýFIC£¨First-in-class£¬£¬£¬£¬£¬¼´Í¬ÀàÊ×´´£©ÓëBIC£¨Best-in-class£¬£¬£¬£¬£¬¼´Í¬Àà×î¼Ñ£©ÐÂÒ©µÄÑо¿ÓëÁÙ´²¿ª·¢ÄÜÁ¦£¬£¬£¬£¬£¬¼ÓËÙÁ¢ÒìÊÖÒպͲúÆ·µÄÑз¢ºÍת»¯Â䵨¡£¡£¡£¡£¡£
ÔÚ¡°4IN¡±£¨Á¢Òì Innovation¡¢¹ú¼Ê»¯ Internationalization¡¢ÖÇÄÜ»¯ Intelligentization¡¢ÕûºÏ Integration£©µÄÕ½ÂÔÖ¸µ¼Ï£¬£¬£¬£¬£¬ÈËÉú¾ÍÊDz«(ZLKS)¼¯ÍÅΨһ¹Ù·½ÍøÕ¾Ò½Ò©³Ð¼Ì¡°Á¢ÒìתÐÍ¡¢ÕûºÏÔËÓª¡¢ÎȽ¡ÔöÌí¡±µÄÉú³¤Ä£Ê½ÒÔ¼°Îª¹É¶«´´Á¢¼ÛÖµµÄÐÅÐÄ£¬£¬£¬£¬£¬Ò»Ö±ÔöÇ¿×ÔÖ÷Ñз¢ÓëÍⲿÏàÖú£¬£¬£¬£¬£¬¸»ºñ²úÆ·¹ÜÏߣ¬£¬£¬£¬£¬Ç¿»¯È«Çò»¯½á¹¹£¬£¬£¬£¬£¬ÌáÉýÔËӪЧÂÊ£¬£¬£¬£¬£¬Í¬Ê±£¬£¬£¬£¬£¬Æð¾¢ÍƽøÒ½ÁÆ¿µ½¡¹¤ÒµÏßÉÏÏßϽṹ£¬£¬£¬£¬£¬ÖÂÁ¦ÓÚ³ÉΪȫÇòÒ½ÁÆ¿µ½¡Êг¡µÄÒ»Á÷ÆóÒµ¡£¡£¡£¡£¡£
Ïàʶ¹«Ë¾¸ü¶à×ÊѶ£¬£¬£¬£¬£¬¿ÉµÇ¼¹ÙÍø£ºwww.fosunpharma.com¡£¡£¡£¡£¡£






